Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 3;14(6):1412-1416.
doi: 10.1080/21645515.2018.1436920. Epub 2018 Feb 26.

Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran

Affiliations

Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran

Shahrokh Izadi et al. Hum Vaccin Immunother. .

Abstract

Eight months after the mass immunization campaign of November 2015 against measles and rubella in the southeast of Iran, in order to evaluate the sero-immunity level of the people living in the mentioned region, a serosurvey study was performed. Using a multi-stage probability proportional to size cluster sampling, the sera of 1,056 participants, ranging from 15 months to 20 years old, were tested for measles and rubella IgG antibodies in the National Reference Laboratory at Tehran University of Medical Sciences, Tehran, Iran. The seroprevalence rates of antibodies against measles and rubella in the age groups below 16 years were respectively 98.4 and 93.2%. In the age group of 16 to 20 years, who was not the target of the mass immunization campaign, the said rates were respectively 91.7% and 87.4%. The herd immunity of the age groups below 16 years, who were the target of the campaign, is favourably high and reassuring both for measles and for rubella. Campaigns of supplementary vaccination play a substantial role for filling the gaps in the herd immunity.

Keywords: Herd immunity; Immunization; Iran; Measles; Rubella; Seroprevalence; Vaccination.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Personnaz D, Larson H. Iran and Turkey launch world's largest measles campaigns Geneva: Unicef; 2003; updated 9 December 2003 [accessed 2016 October 04] http://www.unicef.org/media/media_18172.html.
    1. Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F. Progress in measles and rubella elimination in Iran. Pediatr Infect Dis J. 2007;26(12):1137–41. doi:10.1097/INF.0b013e3181462090. PMID:18043452. - DOI - PubMed
    1. Izadi S, Zahraie SM, Sartipi M. An investigation into a measles outbreak in southeast Iran. Jpn J Infect Dis. 2012;65(1):45–51. PMID:22274157. - PubMed
    1. Karimi A, Arjomandi A, Alborzi A, Rasouli M, Kadivar MR, Obood B, Pourabbas B. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran. East Mediterr Health J. 2004;10(4-5):468–73. PMID:16335636. - PubMed
    1. Immunization , Vaccination and Biologicals; Measles and Rubella Surveillance Data. World Health Organization; 2017; updated 11 September 2017 [accessed 2017 September 29] http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surve....

Publication types

LinkOut - more resources